Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medifast (MED) Return on Sales (2016 - 2025)

Medifast (MED) has disclosed Return on Sales for 16 consecutive years, with 0.24% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Sales fell 25.0% year-over-year to 0.24%, compared with a TTM value of 0.05% through Dec 2025, down 5.0%, and an annual FY2025 reading of 0.05%, down 5.0% over the prior year.
  • Return on Sales was 0.24% for Q4 2025 at Medifast, down from 0.03% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.12% in Q1 2021 and bottomed at 0.24% in Q4 2025.
  • Average Return on Sales over 5 years is 0.04%, with a median of 0.08% recorded in 2022.
  • Peak annual rise in Return on Sales hit 7bps in 2025, while the deepest fall reached -25bps in 2025.
  • Year by year, Return on Sales stood at 0.09% in 2021, then decreased by -13bps to 0.08% in 2022, then crashed by -60bps to 0.03% in 2023, then crashed by -79bps to 0.01% in 2024, then crashed by -3707bps to 0.24% in 2025.
  • Business Quant data shows Return on Sales for MED at 0.24% in Q4 2025, 0.03% in Q3 2025, and 0.02% in Q2 2025.